New York City, NY -- (SBWIRE) -- 01/08/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
StockMarketIntel.com issues a special report on the following stocks: Rouse Properties Inc (NYSE:RSE), Sanofi SA (ADR) (NYSE:SNY), Twitter Inc (NYSE:TWTR), Arca Biopharma Inc (NASDAQ:ABIO)
Rouse Properties Inc (NYSE:RSE) gained 1.06% recently, while trading on 2.30 million shares, at the price of $20.08. The stock changed hands in a range of $19.56 to $20.26 up till now, bringing its market capitalization at about $966.31 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $15.88 and was moved to the maximum level of $25.26. Rouse Properties, Inc. (Rouse) is a real estate investment trust (REIT) company. Rouse is engaged in the operation, development and management of retail rental property. It manages all of its properties, performing the day-to-day functions, operations, leasing, maintenance, marketing and promotional services. Rouse is a wholly owned subsidiary of GGP Limited Partnership (GGPLP), which is majority owned by General Growth Properties, Inc. (GGP). In February 2012, the Company purchased Grand Traverse Mall in Traverse City.
Will RSE Continue To Move Higher? Find Out Here
Sanofi SA (ADR) (NYSE:SNY) declined -1.62% recently, in the current trading session, at $51.07 with a total volume of 1.33 million shares. The stock, on average, trades on a volume of 1.49 million shares. It floated in a range of $51.02 to $51.28 during the recent trading session, with a beta value of 1.01. Its market capitalization now moved to about $136.17 billion. In the past 52 weeks, the share price has not declined below $44.50 or above $55.94. Sanofi SA, formerly Sanofi-Aventis, is a global and diversified healthcare company based in France. The Company discovers, develops and distributes therapeutic solutions focused on patients' needs. The Company focuses on the field of healthcare with six growth platforms.
Will SNY Get Buyers Even After The Recent Rally? Find Out Here
Twitter Inc (NYSE:TWTR) recently recorded a fall of -3.29% and was moving within a range of $57.92-$60.18, its current trading price is $59.42. The stock is moving up till now with a total volume of 6.44 million shares, versus an average volume of 24.57 million shares. The share price hit its 52-week low of $38.80 and $74.73 was the best price. Twitter, Inc. (Twitter) is a global platform for public self-expression and conversation in real time. Twitter is a real-time platform, where any user can create a Tweet and any user can follow other users. Each Tweet is limited to 140 characters of text, but can also contain rich media, including photos, videos and applications. The Company offers Twitter apps for phones, tablets and computers.
Will TWTR Bounce Back After yesterday’s Sharp Sell off? Find Out Here
Arca Biopharma Inc (NASDAQ:ABIO) added 33.34% in its current trading activity, bringing its market capitalization around $37.62 million. The share price, after opening at $2.20, hit a high of $2.54 and hovered above $2.19, while its recent trading price was $2.41. The total number of shares changed hands during the current session up till now was 6.08 million shares, as compared to average trading volume of 1.65 million shares. ARCA biopharma, Inc. (ARCA) is a biopharmaceutical company. The Company's principal focus is developing genetically-targeted therapies for heart failure and other cardiovascular diseases. ARCA's lead product candidate is Gencaro TM (bucindolol hydrochloride), a pharmacologically beta-blocker and mild vasodilator being developed for the treatment of chronic heart failure (HF).
Why Should Investors Buy ABIO After The Recent Gain? Just Go Here and Find Out
To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)